Prospera Financial Services’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Buy |
1,101
+5
| +0.5% | +$1.44K | 0.01% | 1082 |
|
|
2025
Q1 | $338K | Buy |
1,096
+7
| +0.6% | +$2.16K | 0.01% | 940 |
|
|
2024
Q4 | $384K | Buy |
1,089
+14
| +1% | +$4.94K | 0.01% | 831 |
|
|
2024
Q3 | $385K | Sell |
1,075
-2
| -0.2% | -$717 | 0.01% | 823 |
|
|
2024
Q2 | $343K | Sell |
1,077
-10
| -0.9% | -$3.19K | 0.01% | 863 |
|
|
2024
Q1 | $250K | Sell |
1,087
-2
| -0.2% | -$459 | 0.01% | 968 |
|
|
2023
Q4 | $239K | Sell |
1,089
-63
| -5% | -$13.9K | 0.01% | 930 |
|
|
2023
Q3 | $260K | Sell |
1,152
-19
| -2% | -$4.29K | 0.01% | 854 |
|
|
2023
Q2 | $258K | Buy |
+1,171
| New | +$258K | 0.01% | 867 |
|
|
2022
Q2 | – | Sell |
-42
| Closed | -$8K | – | 2568 |
|
|
2022
Q1 | $8K | Buy |
+42
| New | +$8K | ﹤0.01% | 2141 |
|
|
2018
Q1 | – | Sell |
-1,600
| Closed | -$240K | – | 465 |
|
|
2017
Q4 | $240K | Sell |
1,600
-550
| -26% | -$82.5K | 0.04% | 347 |
|
|
2017
Q3 | $263K | Buy |
2,150
+50
| +2% | +$6.12K | 0.04% | 347 |
|
|
2017
Q2 | $277K | Buy |
+2,100
| New | +$277K | 0.04% | 326 |
|